Dashboard
Manage Tickers

ENVBEnveric Biosciences, Inc.

Nasdaq enveric.com


$ 0.52 $ -0.02 (-2.8 %)    

Monday, 26-Aug-2024 09:17:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.45 $ -3.48 (-0.73 %)
DIA $ 413.92 $ 1.07 (0.26 %)
SPY $ 562.02 $ -1.17 (-0.21 %)
TLT $ 98.37 $ -0.28 (-0.28 %)
GLD $ 232.47 $ -1.01 (-0.43 %)
$ 0.535
$ 0.52
$ 0.54 x 299
-- x --
$ 0.52 - $ 0.52
$ 0.41 - $ 2.92
80,409
na
4.77M
$ 1.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-26-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 05-13-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-13-2021 09-30-2021 10-Q
13 08-13-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 04-01-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-25-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 03-26-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
28 11-13-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-31-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-12-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 11-23-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-31-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

enveric-biosciences-granted-us-patent-12065404-today-for-c4-carboxylic-acid-substituted-tryptamine-derivatives-and-methods-used-to-treat-brain-neurological-disorders
Enveric Biosciences Granted US Patent #120...
08/20/2024 19:54:07

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12065404).pn

aries-science--technology-and-enveric-biosciences-announce-issuance-of-key-us-patent-no-12059393-under-aries-license-for-treatment-of-radiation-dermatitis-and-other-conditions
Aries Science & Technology and Enveric Bio...
08/13/2024 12:08:13

Enveric and Aries recently announced a Licensing Agreement for patented topical product aimed at treating radiation dermatitis,...

enveric-biosciences-q2-2024-gaap-eps-023-beats-055-estimate
Enveric Biosciences Q2 2024 GAAP EPS $(0.2...
08/12/2024 21:39:42

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $...

why-merck-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Merck Shares Are Trading Lower By 10%?...
07/30/2024 17:53:26

why-f5-shares-are-trading-higher-by-over-14-here-are-20-stocks-moving-premarket
Why F5 Shares Are Trading Higher By Over 1...
07/30/2024 09:50:34

non-hallucinogenic-psychedelic-treatment-for-mental-health-disorders-shows-potential-to-be-dosed-orally
Non-Hallucinogenic Psychedelic Treatment F...
07/25/2024 12:00:20

Core News & Articles
'MDMA Therapy Gets Support From Prominent ...
07/16/2024 18:51:34

https://www.greenmarketreport.com/mdma-therapy-gets-support-from-prominent-research-group-as-fda-weighs-action/ The paper noted...

aries-science--technology-and-enveric-biosciences-announce-licensing-agreement-eligible-to-receive-milestone-payments-of-up-to-61m-on-future-sales-if-all-conditions-met
Aries Science & Technology And Enveric Bio...
07/15/2024 12:12:00

-SEC Filing

new-patented-psychedelic-drug-brings-hope-for-brain-disorder-therapies
New Patented Psychedelic Drug Brings Hope ...
07/11/2024 18:45:02

Enveric Biosciences has been granted a U.S. patent for EB-002, enhancing protection for treatments targeting brain neurological...

enveric-biosciences-expands-protection-for-eb-002-drug-candidate-with-new-us-patent-includes-broad-claims-for-treating-brain-neurological-disorders
Enveric Biosciences Expands Protection For...
07/10/2024 12:05:19

enveric-biosciences-elevates-eb-003-to-lead-development-candidate-provides-strategic-outlook-and-pipeline-update
Enveric Biosciences Elevates EB-003 To Lea...
06/25/2024 12:03:13

EB-003 is a novel, neuroplastogenic molecule designed to treat severe mental health disorders without the hallucinogenic effect...

Core News & Articles
'Oregon's First-In-Nation Psilocybin Indus...
06/12/2024 18:07:09

https://www.marijuanamoment.net/oregons-first-in-nation-psilocybin-industry-is-struggling-to-find-paying-customers-a-year-after...

on-may-21-enveric-biosciences-received-letter-from-nasdaq-notifying-co-that-it-regained-compliance-with-minimum-stockholders-equity-requirement
On May 21, Enveric Biosciences Received Le...
05/23/2024 12:13:32

- SEC Filing

psychedelics-inspired-meds-for-depression-anxiety-addiction-producer-trims-q1-net-loss-yoy-increases-cash-on-hand
'Psychedelics-Inspired' Meds For Depressio...
05/16/2024 15:25:07

Enveric Biosciences reported on Wednesday financial results for the first quarter of 2024 ended March 31, 2024."We believe ...

enveric-biosciences-q1-2024-gaap-eps-061-beats-078-estimate
Enveric Biosciences Q1 2024 GAAP EPS $(0.6...
05/15/2024 10:11:36

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $...

microdosing-for-depression-psychedelics-biotech-signs-665m-non-binding-deal-to-out-license-novel-psilocin-prodrug-candidate
Microdosing For Depression: Psychedelics B...
05/14/2024 12:00:58

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 12:06:34

cannabinoids-with-chemotherapy-for-breast-cancer-psychedelics-biotech-inks-61m-license-deal-for-patented-methods
Cannabinoids With Chemotherapy For Breast ...
05/08/2024 11:05:57

The news of the licensee deal comes on the heels of the DEA's move to reschedule marijuana, one source of cannabinoids, as ...

Core News & Articles
"FDA Expert Committee Will Review MDMA-Ass...
05/07/2024 15:54:11

https://www.marijuanamoment.net/fda-expert-committee-will-review-mdma-assisted-therapy-for-ptsd-next-month/The Food and Drug Ad...

psyched-dea-revisits-ban-on-two-psychedelics-farewell-russell-newcombe-podcast-episode-on-kanna--more
Psyched: DEA Revisits Ban On Two Psychedel...
04/17/2024 12:42:33

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION